The global creatinine assay kits market projected to grow at a CAGR of 5.3%.
The global creatinine assay kits market is expected to reach USD 245.4 million by 2022 from USD 189.6 million in 2017, at a CAGR of 5.3% Growth in this market is mainly driven by the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders. However, the limited usage of creatinine assay kits in IVD and identification of novel renal dysfunction biomarkers are expected to challenge market growth in the coming years.
Creatinine-PAP test kits are expected to grow at the highest CAGR during the forecast period. Based on type, the market is segmented into Jaffe’s kinetic test kits, Creatinine-PAP test kits, and ELISA test kits.The Creatinine-PAP test kits segment is expected to grow at the highest CAGR during the forecast period.
The fastest growth of this segment is attributed to the increasing demand for more accurate kits and high research funding support for renal research initiatives.
The urine segment is expected to dominate the market during the forecast period. Based on type of sample, the creatinine assay kits market is segmented into blood/serum, urine, and other samples.The urine segment is expected to dominate the market during the forecast period.
The large share of this segment can primarily be attributed to the greater preference for urine samples owing to the ease of sample collection.
Asia to witness the highest growth during the forecast period. In 2017, North America accounted for the largest share of the market followed by Europe.However, Asia is expected to register the highest CAGR during the forecast period.
The high prevalence of CKD and ESRD in this region and the presence of a large undiagnosed population are the major factors driving the growth of the creatinine assay kits market in Asia. The increasing prevalence of infectious diseases and metabolic syndromes in this region is resulting in the high and regular prescription for metabolic tests.
The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 – 33%; Tier 2 - 45%; Tier 3 - 22% • By Designation C-level- 22%; D-level- 28%; Others- 50% • By Region: North America-55%; Europe-24%; Asia -15%; Rest of the World-6%
List of companies profiled in the report • Thermo Fisher Scientific (US) • Merck (Germany) • Abcam (UK) • Abbott Laboratories (US) • Quidel (US) • Enzo Life Sciences (US) • Cayman Chemical (US) • Crystal Chem (US) • Cell Biolabs (US) • GenWay Biotech (US) • BioAssay Systems (US) • Wako Pure Chemical Industries (Japan) • Tulip Diagnostics (India) • BioVision (US) • Arbor Assays (US)
Research Coverage: The report provides an overview of the creatinine assay kits market.It aims at estimating the market size and future growth potential of this market across different segments such as type, type of sample, and region.
Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall creatinine assay kits market and its subsegments.This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies.
The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
Our reports have been used by over 10K customers, including:
The global cardiac marker testing market size is projected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2020, at a CAGR of 8.9%. The growth in the cardiac marker testing market is majorly driven by the growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private...
The global albumin & creatinine tests market size is valued at an estimated USD 987 million in 2020 and is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the forecast period. The growth of the global albumin & creatinine tests market is driven by factors such as growing prevalence of kidney disorders, the rising adoption...
The Europe pre-lit disposable vaginal speculum market is expected to reach US$ 91.46 million by 2027 from US$ 68.39 million in 2019. The market is estimated to grow at a CAGR of 3.8% from 2020 to 2027. Key factors that are driving the market include high prevalence of cervical cancer and increase in government initiatives for cervical cancer...
The Global Oncology Partnering 2015-2020: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Oncology partnering deals Financial deal terms for headline, upfront and royalty...
Cystitis Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Cystitis Global Clinical Trials Review, H2, 2020" provides an overview of Cystitis Clinical trials scenario.This report provides top line data relating to the clinical trials on Cystitis. Report includes an overview...
Market Introduction This research report provides insights into the Middle East & Africa Medical Devices market.A medical device can be a machine, instrument, apparatus, an article that is used to diagnose, monitor, and therapeutic purposes. A medical device plays an essential role, such as detection, measurement, restoration, and...
The Asia Pacific pre-lit disposable vaginal speculum market is expected to reach US$ 79.35 million by 2027 from US$ 57.80 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027. Key factors that are driving the market include high prevalence of cervical cancer and increase in government initiatives for cervical...
The global male infertility market is expected to reach US$ 6,213.96 million by 2027 from US$ 3,883.82 million in 2019; it is estimated to grow at a CAGR of 6.2% from 2020 to 2027. Factors such as increase in male infertility worldwide and technological advancements fuel the market growth. However, the high cost of procedures hinders the male...
The Global Molecular Diagnostics Partnering Terms and Agreements 2014-2020 report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This...
Coagulation Analyzers - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Coagulation Analyzers - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Coagulation Analyzers pipeline products with comparative analysis of the products...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.